![Insights from 2023 ASH Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2023/12/d8f4a042-951d-471d-8892-527b15ad5587.png.200x0_q85.png)
Insights from 2023 ASH Annual Meeting
Playback speed
10 seconds
FLT3-ITD Mutated AML: PROs From the QuANTUM-First Trial of Quizartinib vs. Standard Chemo
By
Insights from 2023 ASH Annual Meeting
FEATURING
Esther Oliva
By
Insights from 2023 ASH Annual Meeting
FEATURING
Esther Oliva
116 views
March 22, 2024
Login to view comments.
Click here to Login
Leukemia